0.8
MG
SUBCUTANEOUS, INTRAVENOUS
POWDER FOR SOLUTION
Marketed
[ "gonadorelin acetate" ]
[ "Synthetic Peptides" ]
[ "Gonadotropin-Releasing Hormone (GnRH) Agonists" ]
[]